Literature DB >> 12878801

Measles in Europe in 2001-2002.

M Muscat1, S Glismann, H Bang.   

Abstract

A total of 17 928 measles cases were reported to EUVAC.NET in 2001-02, with a 41% increase between the 2 years, giving a crude incidence of 2.36 and 3.37 per 100 000 population respectively. Most reported cases were aged 1-9 years. Outbreak related measles cases amounted to 18% of reported cases in 2001 and 20% in 2002. Less than 1% of cases were known to be imported in 2001 and 2002. Encephalitis as a severe complication was reported in 21 in 2001 and 6 cases 2002. One death attributed to measles was reported in 2001. The proportion of reported cases with known vaccination status increased from 56% of cases in 2001 to 72% in 2002. Overall, the proportion of reported measles cases that were unvaccinated rose from 50% in 2001 to 66% in 2002.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12878801     DOI: 10.2807/esm.08.06.00414-en

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  7 in total

1.  Acute measles encephalitis in adults.

Authors:  Yasuhiko Baba; Yoshio Tsuboi; Hirosato Inoue; Tatsuo Yamada; Zbigniew K Wszolek; Daniel F Broderick
Journal:  J Neurol       Date:  2005-08-25       Impact factor: 4.849

2.  Measles outbreaks affecting children in Jewish ultra-orthodox communities in Jerusalem.

Authors:  C Stein-Zamir; G Zentner; N Abramson; H Shoob; Y Aboudy; L Shulman; E Mendelson
Journal:  Epidemiol Infect       Date:  2007-04-16       Impact factor: 2.451

3.  Modulation of disease, T cell responses, and measles virus clearance in monkeys vaccinated with H-encoding alphavirus replicon particles.

Authors:  Chien-Hsiung Pan; Alexandra Valsamakis; Teresa Colella; Nitya Nair; Robert J Adams; Fernando P Polack; Catherine E Greer; Silvia Perri; John M Polo; Diane E Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-21       Impact factor: 11.205

4.  Kinetics of decline of maternal measles virus-neutralizing antibodies in sera of infants in France in 2006.

Authors:  Arnaud Gagneur; Didier Pinquier; Marie Aubert; Laurent Balu; Olivier Brissaud; Loïc De Pontual; Christèle Gras Le Guen; Isabelle Hau-Rainsard; Olivier Mory; Georges Picherot; Jean-Louis Stephan; Bernard Cohen; Evelyne Caulin; Benoît Soubeyrand; Philippe Reinert
Journal:  Clin Vaccine Immunol       Date:  2008-09-24

5.  Differential immune responses to primary measles-mumps-rubella vaccination in Israeli children.

Authors:  Bracha Rager-Zisman; Elina Bazarsky; Agneta Skibin; Guy Tam; Shlomo Chamney; Ilana Belmaker; Iris Shai; Ella Kordysh; Diane E Griffin
Journal:  Clin Diagn Lab Immunol       Date:  2004-09

Review 6.  Measles, mumps, rubella vaccine (Priorix; GSK-MMR): a review of its use in the prevention of measles, mumps and rubella.

Authors:  Keri Wellington; Karen L Goa
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 7.  The role of the traveler in emerging infections and magnitude of travel.

Authors:  Lin H Chen; Mary Elizabeth Wilson
Journal:  Med Clin North Am       Date:  2008-11       Impact factor: 5.456

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.